bpc 157 fda status 2025 Peptide Reclassification 2026: What It Means for Providers 7 peptides under FDA review:

When paired with calibrated instruments and consistent documentation, the format supports comparability across runs and between teams

The distinction between CPT 20605 (intermediate joints) and CPT 20610 (major joints) matters most for elbow, wrist, and ankle claims: the primary large articulations at these locations (tibiotalar, humeroulnar, and radiocarpal) qualify for CPT 20610, while smaller associated articulations at the same anatomical region qualify for CPT 20605

Pleguezuelos O, James E, Fernandez A, Lopes V, Rosas LA, Cervantes-Medina A, et al

Confounding factors: Natural disease fluctuation, seasonal variations, medication changes, other health changes (new diabetes diagnosis, blood pressure changes)

Testing MMA levels provides a sensitive indicator of functional vitamin B12 status in the body

doi: 10.1186/s12967-018-1427-5